Abstract

Chronic necrotizing pulmonary aspergillosis is characterized by a pulmonary infiltration with cavitation in patients with chronic pulmonary disease, slight immunodeficiency or healthy patients. A 57-year-old man with non-small cell carcinoma who has had radiotherapy was admitted with a history of left side pleuritic chest pain, non-productive cough, fever and dyspnea. Aspergillus fumigatus was found in his mycological exams of BAL fluid. Serum examination presented positive galactomannan. Final diagnosis was semi-invasive pulmonary aspergillosis treated with voriconazole.

Highlights

  • Chronic necrotizing pulmonary aspergillosis (CNPA), called semi-invasive pulmonary aspergillosis, was first described in the early 1980s as a distinct type of pulmonary aspergillosis [1]

  • There are a few reports in the literature that semiinvasive aspergillosis can occur in adults following radiotherapy [3,4]

  • We presented chronic necrotizing pulmonary aspergillosis in a patient with non-small cell lung carcinoma (NSCLC) following radiotherapy

Read more

Summary

Introduction

Chronic necrotizing pulmonary aspergillosis (CNPA), called semi-invasive pulmonary aspergillosis, was first described in the early 1980s as a distinct type of pulmonary aspergillosis [1]. We presented chronic necrotizing pulmonary aspergillosis in a patient with non-small cell lung carcinoma (NSCLC) following radiotherapy. A 57-year-old man was admitted to our pulmonary outpatient clinic with a history of left side pleuritic chest pain, non-productive cough, fever and dyspnea for 3 days He was diagnosed NSCLC nine months ago. Chest radiology revealed a cavitary lesion of middle and lower lung field (Figure 1) and on HRCT there was a 50×37 mm solid mass lesion in the left hilum surrounding left upper bronchus (Figure 2) and 12×8 cm cavitary lesion on the segments of the left lung lobe with air-liquid level (Figure 3) He was used different therapy of antibiotics for a month but there was no clinical response to that treatment. Our final diagnosis was semiinvasive pulmonary aspergillosis and we started him on voriconazole (400 mg per day, orally)

Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.